These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27646018)

  • 41. The benefit and risk of postmastectomy radiation therapy in patients with high-risk breast cancer.
    Cheng SH; Jian JJ; Chan KY; Tsai SY; Liu MC; Chen CM
    Am J Clin Oncol; 1998 Feb; 21(1):12-7. PubMed ID: 9499249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.
    Stauder MC; Caudle AS; Allen PK; Shaitelman SF; Smith BD; Hoffman KE; Buchholz TA; Chavez-Macgregor M; Hunt KK; Meric-Bernstam F; Woodward WA
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):637-44. PubMed ID: 27681760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 44. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.
    Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
    Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postmastectomy radiotherapy of the chest wall. Comparison of electron-rotation technique and common tangential photon fields.
    Hehr T; Classen J; Huth M; Durst I; Christ G; Bamberg M; Budach W
    Strahlenther Onkol; 2004 Oct; 180(10):629-36. PubMed ID: 15480511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.
    Nagar H; Mittendorf EA; Strom EA; Perkins GH; Oh JL; Tereffe W; Woodward WA; Gonzalez-Angulo AM; Hunt KK; Buchholz TA; Yu TK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):782-7. PubMed ID: 21885207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of patients with locally advanced breast cancer.
    Lee MC; Newman LA
    Surg Clin North Am; 2007 Apr; 87(2):379-98, ix. PubMed ID: 17498533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiotherapy of breast cancer.
    Hennequin C; Belkacémi Y; Bourgier C; Cowen D; Cutuli B; Fourquet A; Hannoun-Lévi JM; Pasquier D; Racadot S; Rivera S
    Cancer Radiother; 2022; 26(1-2):221-230. PubMed ID: 34955414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy.
    Gilmore RC; Sebai ME; Psoter KJ; Prasath V; Siotos C; Broderick KP; Jacobs LK; Harvey SC; Habibi M
    Sci Rep; 2020 Jun; 10(1):9887. PubMed ID: 32555240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes.
    Weiss A; Lin H; Babiera GV; Bedrosian I; Shaitelman SF; Shen Y; Kuerer HM; Mittendorf EA; Caudle AS; Hunt KK; Hwang RF
    Breast Cancer Res Treat; 2019 Jul; 176(2):435-444. PubMed ID: 31025270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
    Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
    Kantor O; Means J; Grossmith S; Dey T; Bellon JR; Mittendorf EA; King TA
    Ann Surg Oncol; 2022 Feb; 29(2):972-980. PubMed ID: 34467507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese Breast Cancer Registry.
    Yamada A; Hayashi N; Kumamaru H; Nagahashi M; Usune S; Asaga S; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Ogo E; Tamura K; Tanakura K; Tada K; Niikura N; Yoshida M; Ohno S; Ishikawa T; Narui K; Endo I; Imoto S; Jinno H
    Eur J Cancer; 2022 Sep; 172():31-40. PubMed ID: 35752154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
    Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
    Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.
    Smith BD; Smith GL; Haffty BG
    J Clin Oncol; 2005 Mar; 23(7):1409-19. PubMed ID: 15735117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ASTRO Radiation Therapy Summary of the ASCO-ASTRO-SSO Guideline on Management of Hereditary Breast Cancer.
    Trombetta MG; Dragun A; Mayr NA; Pierce LJ
    Pract Radiat Oncol; 2020; 10(4):235-242. PubMed ID: 32471709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.